The first half of 2026 saw a surge in AI investments pushing tech stocks to new highs, while Bitcoin fell about 46%, creating a sharp divide in markets. Analysts say the second half will focus on which companies truly benefit from AI, amid ongoing macroeconomic uncertainty and Federal Reserve policy impacts. Bitcoin's recent drop aligns with historical bear cycles, with some experts seeing a potential buying opportunity near $54,000-$58,000. Overall, heightened volatility is expected in both stocks and cryptocurrencies as investors shift focus to fundamentals over broad optimism.
Dimensional Fund Advisors Ltd disclosed a sale of 730,460 ordinary shares of Beazley PLC, reducing its holding to 0.89% as of June 30, 2026. This transaction reflects a partial exit from their investment in Beazley PLC. The sale price per share was a...
The global pyrometer market, valued at $544.55 million in 2025, is projected to reach $1.15 billion by 2035, growing at a CAGR of 7.57%. This growth is fueled by rising industrial automation and expansion in semiconductor manufacturing, which increas...
Abeona Therapeutics announced it granted restricted stock awards to five new non-executive employees as an inducement to join the company, totaling up to 9,000 shares. These shares will vest over three years, contingent on continued employment. This ...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against BitGo Holdings, ADMA Biologics, and Erasca. The lawsuits allege these companies made false or misleading statements affe...
Step Pharma has appointed Neil J. Gallagher, MD, PhD, as a Non-Executive Director to strengthen its board as it advances dencatistat, a first-in-class CTPS1 inhibitor targeting essential thrombocythaemia, lymphoma, and solid tumours. Gallagher brings...
